Femasys, Inc. (FEMY)
1.75
-0.25
(-12.50%)
USD |
NASDAQ |
Oct 12, 16:00
1.67
-0.08
(-4.57%)
Pre-Market: 08:46
Femasys EPS Diluted (Quarterly) : -1.331 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.331 |
| March 31, 2026 | 0.0842 |
| December 31, 2025 | -1.326 |
| September 30, 2025 | -2.045 |
| June 30, 2025 | -3.176 |
| March 31, 2025 | -0.2345 |
| December 31, 2024 | -4.495 |
| September 30, 2024 | -0.2433 |
| June 30, 2024 | -0.2109 |
| March 31, 2024 | -0.1653 |
| December 31, 2023 | -0.2036 |
| September 30, 2023 | -0.2648 |
| June 30, 2023 | -0.2208 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2482 |
| December 31, 2022 | -0.2452 |
| September 30, 2022 | -0.2525 |
| June 30, 2022 | -0.223 |
| March 31, 2022 | -0.2442 |
| December 31, 2021 | -0.2003 |
| September 30, 2021 | -0.1915 |
| June 30, 2021 | -0.0918 |
| March 31, 2021 | -0.1505 |
| December 31, 2020 | -0.1411 |
| September 30, 2020 | -0.1333 |
| June 30, 2020 | -0.1259 |
| March 31, 2020 | -0.1811 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.469M |
| Revenue (Quarterly) | 0.3318M |
| Total Expenses (Quarterly) | 4.801M |
| Enterprise Value | 8.639M |
| Gross Profit Margin (Quarterly) | -2.41% |
| Profit Margin (Quarterly) | -1.35K% |
| Earnings Yield | -263.9% |
| Normalized Earnings Yield | -342.79 |